mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.4 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |